STRO
Sutro Biopharma, Inc.Company with tickers: STRO
CIK
1382101
CUSIP
869367201
Shares Outstanding
16,570,439
13F Activity (30d)
69 filings
69 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $14,523,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $44,179,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $36,553,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-29,656,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-38,484,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-2.94 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-2.94 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |